Publications by authors named "Anand Swaminath"

Claim this Profile
S
So Long, Olden Days.
Brandon M Meyers, Anand Swaminath

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life of Stereotactic Versus Hypofractionated Radiation Therapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results From the LUSTRE Trial.
Qirui Hou, Sameer Parpia, Marcin Wierzbicki, Vijayananda Kundapur, Sergio Faria, Anand Swaminath

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney.
Muhammad Ali, Rohann J M Correa, David Pryor, Braden Higgs, Swetha Sridharan, Anand Swaminath

Int J Radiat Oncol Biol Phys· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric Outcomes of Stereotactic Body Radiation Therapy to Ultracentral Lung Tumors: Lessons From the SUNSET Trial.
Rohan Salunkhe, David A Palma, Andrew Warner, Houda Bahig, Joanna M Laba, Anand Swaminath

Int J Radiat Oncol Biol Phys· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate Cancer.
Andre Gouveia, Aruz Mesci, Naghmeh Isfahanian, Ian Dayes, Kimmen Quan, Anand Swaminath

Prostate· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER).
Raees Cassim, Rahul Bansal, Braden Millan, Oleg Mironov, Priya Ahir, Anand Swaminath

Urology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial.
Constanza Vargas, Joe Carrello, Mathias Bressel, Mark Sidhom, Charles Lin, Anand Swaminath

Int J Radiat Oncol Biol Phys· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: Comment on Wu et al's article on toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer.
Che Hsuan David Wu, Timothy J Whelan, Anand Swaminath

Radiother Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis.
Ryan S Huang, Ronald Chow, Ali Benour, David Chen, Gabriel Boldt, Anand Swaminath

Lancet Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial.
Laura A Dawson, Kathryn A Winter, Jennifer J Knox, Andrew X Zhu, Sunil Krishnan, Anand Swaminath

JAMA Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide.
Andrew B Barbour, Rituraj Upadhyay, August C Anderson, Tugce Kutuk, Ritesh Kumar, Anand Swaminath

Pract Radiat Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer.
Muhammad Ali, Young Suk Kwon, Kendrick Koo, Anna Bruynzeel, David Pryor, Anand Swaminath

BJU Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial.
Che Hsuan David Wu, Marcin Wierzbicki, Sameer Parpia, Vijayananda Kundapur, Alexis Bujold, Anand Swaminath

Radiother Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic ablative radiotherapy for primary kidney cancer - An international patterns of practice survey.
Katherine Taplin, Raquibul Hannan, Simon S Lo, Scott C Morgan, Muhammad Ali, Anand Swaminath

Clin Transl Radiat Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney.
Vivian S Tan, Rohann J M Correa, Andrew Warner, Muhammad Ali, Alexander Muacevic, Anand Swaminath

Eur Urol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET).
Meredith E Giuliani, Edith Filion, Sergio Faria, Vijayananda Kundapur, Thi Trinh Thuc Toni Vu, Anand Swaminath

Int J Radiat Oncol Biol Phys· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.
Anand Swaminath, Sameer Parpia, Marcin Wierzbicki, Vijayananda Kundapur, Sergio Faria

JAMA Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.
Fiorella Di Pastena, Gregory Pond, Evangelia E Tsakiridis, Andre Gouveia, Elham Ahmadi, Anand Swaminath

Radiat Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroanatomical location of lung cancer brain metastases in 234 patients with a focus on cancer subtyping and biomarkers.
Michael Bonert, Jens Schittenhelm, Housne Begum, Jian-Qiang Lu, Anand Swaminath

PLoS One· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review.
August C Anderson, Joel Ho, Evan T Hall, Raquibul Hannan, Jay J Liao, Anand Swaminath

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Radiotherapy for Renal Cell Carcinoma-A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings.
Conrad Josef Q Villafuerte, Anand Swaminath

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Volumetric Response Assessment From SABR for Renal Cell Carcinoma.
Daniel G Schep, Jasmin Vansantvoort, Ian Dayes, Himanshu Lukka, Kimmen Quan, Anand Swaminath

Int J Radiat Oncol Biol Phys· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors.
Elysia K Donovan, Simon S Lo, Sushil Beriwal, Hanbo Chen, Patrick Cheung, Anand Swaminath

JAMA Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Luisa M Cardenas, Samantha Sigurdson, Christopher J D Wallis, Aly-Khan Lalani, Anand Swaminath

CMAJ· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the management of renal cell carcinoma.
Luisa M Cardenas, Samantha Sigurdson, Christopher J D Wallis, Aly-Khan Lalani, Anand Swaminath

CMAJ· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis